Rivastigmine Tartrate

CAS 129101-54-8 12 FDA-DMF suppliersSmall Molecule

Overview

Rivastigmine Tartrate is an acetylcholinesterase inhibitor used for the treatment of mild to moderate dementia associated with Alzheimer's and Parkinson's disease. It works by increasing the amount of acetylcholine, a neurotransmitter involved in memory and cognition, in the brain.

API suppliers (14)

Suppliers of Rivastigmine Tartrate backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

  • Apotex Inc.Canada1 active DMF
  • ORBION PHARMACEUTICALS PRIVATE LTDIndia1 active DMF
  • ERREGIERRE SPAItaly1 active DMF
  • ORBION PHARMACEUTICALS PRIVATE LTDIndia1 active DMF
  • Apotex Inc.Canada1 active DMF
  • ERREGIERRE SPAItaly1 active DMF
  • ORBION PHARMACEUTICALS PRIVATE LTDIndia1 active DMF
  • Apotex Inc.Canada1 active DMF
  • Macleods Pharmaceuticals Ltd.India1 active DMF
  • JUBILANT BIOSYS LTD1 active DMF
  • EXCELLA GMBH
  • Emcure Pharmaceuticals LimitedIndia
  • INTERQUIM SA
  • Zhejiang Hisun Pharmaceutical Co., Ltd.China

Therapeutic areas

NeurologyPsychiatry

Related APIs

Aripiprazole
45 suppliers
Pregabalin
40 suppliers
Lurasidone Hydrochloride
35 suppliers
Lamotrigine
33 suppliers
Quetiapine Fumarate
29 suppliers
Risperidone
27 suppliers
Escitalopram Oxalate
27 suppliers
Olanzapine
27 suppliers

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo